Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $79.22 | $37.24 | 112.74% | 52.46x | 38.07x | 8.77x | 10.40x | 0.78x | $194.62M | 2.30% | $833.74M | 7.82 | $8.58B | 77.36 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $34.05 | $8.32 | 309.46% | 162.14x | 78.13x | 9.58x | 19.40x | 1.39x | $39.15M | 0.88% | $220.58M | 1.69 | $4.36B | 96.04 | ||
| RPRX | ROYALTY PHARMA PLC | $67.56 | $36.85 | 83.33% | 35.94x | 12.45x | 11.86x | 3.97x | 0.72x | $2.92B | 9.72% | $9.79B | 21.99 | $47.00B | 39.96 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $316.13 | $74.27 | 325.64% | 119.29x | 32.91x | 24.86x | 6.57x | 1.53x | $90.43M | 1.43% | $961.76M | 48.18 | $7.42B | 75.35 | ||
| HALO | HALOZYME THERAPEUTICS INC | $130.34 | $71.59 | 82.08% | 36.61x | 14.46x | 9.19x | 103.06x | 0.71x | $806.22M | 5.27% | $143.54M | 1.22 | $16.78B | 23.35 | ||
| KRYS | KRYSTAL BIOTECH INC | $310.84 | $77.26 | 302.35% | 40.58x | 41.44x | 19.58x | 6.42x | 2.24x | $310.08M | 3.37% | $1.44B | 48.48 | $8.76B | 32.98 | ||
| VCEL | VERICEL CORP | $45.48 | $8.09 | 462.17% | 94.75x | 80.70x | 7.58x | 6.29x | 2.32x | $61.66M | 2.65% | $370.04M | 7.25 | $2.30B | 52.13 | ||
| TGTX | TG THERAPEUTICS INC | $61.63 | $22.66 | 171.94% | 20.01x | 60.12x | 10.93x | 15.62x | 2.23x | $17.39M | 0.20% | $604.08M | 4.26 | $9.70B | 69.69 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $234.66 | $129.19 | 81.64% | 64.47x | 15.51x | 3.22x | 3.59x | 0.62x | $1.65B | 10.89% | $4.19B | 64.79 | $18.66B | 16.28 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $96.12 | $14.60 | 558.47% | 67.22x | 74.05x | 7.95x | 10.63x | 3.63x | $197.20M | 2.62% | $710.19M | 9.08 | $7.48B | 49.19 | ||
| ADMA | ADMA BIOLOGICS INC | $10.48 | $7.06 | 48.51% | 14.56x | 13.17x | 4.67x | 5.75x | 0.85x | $116.47M | 4.87% | $408.21M | 1.79 | $2.41B | 10.34 | ||
| EXEL | EXELIXIS INC | $72.75 | $31.86 | 128.33% | 21.09x | 21.10x | 7.19x | 9.68x | 1.38x | $1.16B | 6.47% | $1.83B | 7.43 | $17.61B | 15.76 | ||
| INCY | INCYTE CORP | $122.85 | $53.71 | 128.73% | 58.78x | 36.61x | 4.15x | 4.44x | 0.83x | $684.87M | 2.74% | $5.64B | 27.76 | $21.79B | 24.30 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $549.04 | $153.42 | 257.86% | 35.04x | 28.66x | 10.75x | 6.66x | 2.05x | $3.20B | 2.30% | $20.91B | 82.48 | $140.70B | 27.94 | ||
| TECH | BIO-TECHNE CORP | $72.73 | $16.49 | 341.06% | 62.16x | 35.01x | 9.34x | 5.41x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.43B | 32.88 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.17 | $6.39 | 74.73% | 8.80x | 10.27x | 4.49x | 2.78x | 7.44x | $87.07M | 13.12% | $238.92M | 4.02 | $543.75M | 5.66 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $930.67 | $459.63 | 102.48% | 19.80x | 14.46x | 5.60x | 2.87x | 1.16x | $3.83B | 4.04% | $33.50B | 329.39 | $95.32B | 15.26 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $34.42 | $31.40 | 9.62% | 10.96x | 8.30x | 2.08x | 2.01x | 0.62x | $354.90M | 17.80% | $999.24M | 17.25 | $1.61B | 5.74 | ||
| UTHR | UNITED THERAPEUTICS CORP | $608.49 | $205.57 | 196.00% | 20.12x | 22.31x | 8.22x | 4.08x | 2.84x | $1.09B | 4.22% | $6.40B | 150.24 | $24.30B | 14.49 | ||
| VCYT | VERACYTE INC | $52.52 | $12.05 | 335.68% | 36.47x | 27.07x | 7.48x | 3.04x | 2.95x | $165.99M | 3.95% | $1.39B | 17.36 | $3.96B | 28.36 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.